086820 — Bio Solution Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩122bn
- KR₩122bn
- KR₩12bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,882 | 7,744 | 11,802 | 10,102 | 12,462 |
Cost of Revenue | |||||
Gross Profit | 5,902 | 4,300 | 7,608 | 5,927 | 8,120 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,750 | 11,074 | 13,374 | 15,390 | 17,492 |
Operating Profit | -1,868 | -3,330 | -1,572 | -5,289 | -5,031 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -698 | -1,800 | -1,685 | -8,087 | -1,249 |
Provision for Income Taxes | |||||
Net Income After Taxes | -698 | -1,800 | -1,685 | -8,087 | -1,249 |
Net Income Before Extraordinary Items | |||||
Net Income | -698 | -1,800 | -1,685 | -8,087 | -1,249 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -698 | -1,800 | -1,685 | -8,087 | -1,249 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -89 | -226 | -212 | -1,009 | -156 |
Dividends per Share |